Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Gross Profit (2023 - 2025)

Bioregenx's Gross Profit history spans 3 years, with the latest figure at $318775.0 for Q4 2025.

  • Quarterly results put Gross Profit at $318775.0 for Q4 2025, down 1.23% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 9.33% YoY), and the annual figure for FY2025 was $1.5 million, down 9.33%.
  • Gross Profit for Q4 2025 was $318775.0 at Bioregenx, down from $426397.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $763891.0 in Q1 2023 to a low of $318775.0 in Q4 2025.
  • The 3-year median for Gross Profit is $416214.0 (2025), against an average of $456125.7.
  • The sharpest move saw Gross Profit plummeted 49.71% in 2024, then grew 5.69% in 2025.
  • Year by year, Gross Profit stood at $378025.0 in 2023, then decreased by 14.63% to $322737.0 in 2024, then decreased by 1.23% to $318775.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $318775.0, $426397.0, and $352456.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.